Key Events This Week
2 Feb: Stock plunges 10.45% to Rs.265.55
3 Feb: Strong gap up and intraday high at Rs.290 (+7.96%)
4 Feb: Moderate gain of 1.59% to Rs.291.50
5 Feb: Slight dip of 0.22% to Rs.290.85
6 Feb: Week closes lower at Rs.287.00 (-1.32%)

Advanced Enzyme Technologies Ltd Hits Intraday High with 7.96% Surge
2026-02-03 11:21:23Advanced Enzyme Technologies Ltd recorded a robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 290, marking a 9.21% increase from its previous close. The stock outperformed its sector and broader market indices, reflecting notable trading momentum and a reversal after a three-day decline.
Read full news article
Advanced Enzyme Technologies Ltd Opens Strong with Significant Gap Up on 3 Feb 2026
2026-02-03 09:57:04Advanced Enzyme Technologies Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a significant gap up of 5.84%, reflecting positive market sentiment despite prevailing bearish technical indicators. The stock outperformed its sector and benchmark indices, signalling a notable shift in intraday momentum.
Read full news article
Advanced Enzyme Technologies Ltd Hits Intraday Low Amid Price Pressure
2026-02-01 14:47:19Advanced Enzyme Technologies Ltd experienced a notable decline today, touching an intraday low of Rs 277, reflecting sustained price pressure amid broader market weakness and sector underperformance.
Read full news articleAre Advanced Enzyme Technologies Ltd latest results good or bad?
2026-01-31 19:25:13The latest financial results for Advanced Enzyme Technologies Ltd for the quarter ended December 2025 present a complex picture of the company's performance. The company reported a net profit of ₹42.50 crores, reflecting a year-on-year growth of 12.88%, which is a notable improvement compared to the previous year. However, revenue for the same quarter was ₹171.95 crores, showing a sequential decline of 6.82% from the previous quarter, although it did exhibit a modest year-on-year growth of 1.68%. This juxtaposition raises questions about the sustainability of demand within the enzyme manufacturing sector. The operating margin, excluding other income, decreased to 28.70%, marking a significant contraction of 385 basis points from the prior quarter. This decline in operating efficiency is concerning, as it is the lowest margin reported in the last seven quarters. The profit after tax margin improved slightly...
Read full news article
Advanced Enzyme Technologies Q3 FY26: Profit Growth Masks Margin Erosion Concerns
2026-01-31 14:47:18Advanced Enzyme Technologies Ltd., India's largest enzyme manufacturer, reported consolidated net profit of ₹42.50 crores for Q3 FY26, registering a modest decline of 1.92% quarter-on-quarter but achieving a respectable 12.88% year-on-year growth. The ₹3,262 crore market capitalisation company, however, faces mounting concerns as operating margins contracted sharply despite revenue stability, whilst the stock trades 19.52% below its 52-week high of ₹366.55, reflecting investor unease over deteriorating operational efficiency.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-01-28 10:10:05Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 21 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Advanced Enzyme Technologies Ltd Faces Bearish Momentum Amid Technical Downturn
2026-01-09 08:07:44Advanced Enzyme Technologies Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 21 Nov 2025, reflecting deteriorating technical conditions and a weakening price trajectory amid broader market pressures.
Read full news article
Advanced Enzyme Technologies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-01-08 08:19:03Advanced Enzyme Technologies Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite a modest day gain of 1.37%, the stock’s broader technical landscape reveals a complex interplay of bearish and bullish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article





